<code id='63348A4697'></code><style id='63348A4697'></style>
    • <acronym id='63348A4697'></acronym>
      <center id='63348A4697'><center id='63348A4697'><tfoot id='63348A4697'></tfoot></center><abbr id='63348A4697'><dir id='63348A4697'><tfoot id='63348A4697'></tfoot><noframes id='63348A4697'>

    • <optgroup id='63348A4697'><strike id='63348A4697'><sup id='63348A4697'></sup></strike><code id='63348A4697'></code></optgroup>
        1. <b id='63348A4697'><label id='63348A4697'><select id='63348A4697'><dt id='63348A4697'><span id='63348A4697'></span></dt></select></label></b><u id='63348A4697'></u>
          <i id='63348A4697'><strike id='63348A4697'><tt id='63348A4697'><pre id='63348A4697'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:2328
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          FDA panel signals lack of confidence in Amgen cancer drug data
          FDA panel signals lack of confidence in Amgen cancer drug data

          AdobeTheclearanceofafirst-of-its-kindcancertreatmentmadebyAmgenisonshakiergroundfollowingaFoodandDru

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

          AmandaAndrade-Rhoades/APU.S.regulatorsapprovedalabelexpansionforNovoNordisk’sobesitydrugWegovytotout